Maria R. Garcia-Gomez

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Association of Parkinson's disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records.

Association of Parkinson's disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records.

Journal: BMJ open

Published: June 22, 2019

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study.

Journal: Alimentary pharmacology & therapeutics

Published: August 30, 2017

Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Journal: Drugs in context

Published: June 30, 2017

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Journal: The American journal of gastroenterology

Published: April 09, 2016

Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: relation with risk and phenotype in a Spanish cohort.

Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: relation with risk and phenotype in a Spanish cohort.

Journal: Immunobiology

Published: March 05, 2016

MICAA4 protects against ulcerative colitis, whereas MICAA5.1 is associated with abscess formation and age of onset.

MICAA4 protects against ulcerative colitis, whereas MICAA5.1 is associated with abscess formation and age of onset.

Journal: Clinical and experimental immunology

Published: March 01, 2016

Initial experience with golimumab in clinical practice for ulcerative colitis.

Initial experience with golimumab in clinical practice for ulcerative colitis.

Journal: Revista espanola de enfermedades digestivas

Published: January 21, 2016

Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.

Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's Disease.

Journal: Journal of Crohn's & colitis

Published: November 11, 2015

Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.

Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.

Journal: Inflammatory bowel diseases

Published: June 13, 2015

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile.

Journal: Mediators of inflammation

Published: December 16, 2014

Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab.

Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab.

Journal: Human immunology

Published: July 01, 2013

Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents

Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents

Journal: Gastroenterologia y hepatologia

Published: June 20, 2013

Showing 1-12 of 40

Last Updated: 09/26/2026